Moleculin Biotech (MBRX) Total Liabilities (2015 - 2026)
Moleculin Biotech's Total Liabilities came in at $9.5 million for Q2 2026, down 56.0% from $21.6 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Total Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Total Liabilities was $7.12 million, up 24.5% from FY2024.
- Total Liabilities carries a five-year compound annual growth rate of -8.8% (FY2020 to FY2025).
- Going back by year, Total Liabilities was $5.72 million in FY2024 (-21.6%), $7.29 million in FY2023 (+39.3%), $5.23 million in FY2022 (+2.6%) and $5.1 million in FY2021 (-54.8%).
- The five-year range for quarterly Total Liabilities is $4.39 million (Q3 2023) to $47.27 million (Q3 2025).
- Year-over-year, Total Liabilities increased in five of the last seven quarters, with growth averaging 135.3%.
- The fastest year-over-year change in Total Liabilities over five years came in Q3 2025 (growth of 690.1%), and the weakest in Q2 2026 (a decline of 56.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Moleculin Biotech | 34.99 Mn | 4.59 Mn | - | 9.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.50 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Sep 30, 2025 | 47.27 Mn |
| Jun 30, 2025 | 21.60 Mn |
| Mar 31, 2025 | 7.22 Mn |
| Dec 31, 2024 | 5.72 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 5.86 Mn |
| Dec 31, 2023 | 7.29 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Mar 31, 2023 | 5.38 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 6.96 Mn |
| Jun 30, 2022 | 6.90 Mn |
| Mar 31, 2022 | 6.14 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 7.44 Mn |
| Jun 30, 2021 | 8.83 Mn |
API Access
Moleculin Biotech Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();